EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome

Josiah A Peter iD, Thomas A Weiser iD, Lee A Niswander iD, Robert T Batey iD, Deborah S Wuttke iD

Nucleic Acids Research · 2026

DOI: 10.1093/nar/gkag890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Josiah A Peter und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, U.S.A. Hauptthemen laut MEDLINE: Methyl-CpG-Binding Protein 2, Rett Syndrome, DNA, RNA. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rett syndrome neurodevelopmental disorder is caused by mutations in the epigenetic regulator MeCP2. While the MeCP2 methyl-CpG binding domain (MBD) is well-characterized, the function of the adjacent intervening domain (ID) remains largely understudied. The ID has been described as a distinct RNA-binding region, yet evidence also suggests RNA competitively displaces MeCP2 from DNA. Here, we address these conflicting findings by demonstrating the MBD and ID do not function in isolation but as a synergistic functional unit. The ID significantly enhances affinity of the MBD for methylated DNA by ∼35-fold. Moreover, these two subdomains form a high-affinity RNA-binding module, with preference for structured RNAs increased over 1000-fold compared to the MBD or ID alone. We find binding to RNA precludes binding to DNA, such that the integrated MBD-ID unit explains the competition phenomenon. Analysis of Rett syndrome-associated ID mutations (R167W, K174Q, and R190H) and a therapeutic MiniGene reveals they do not disrupt methyl-DNA binding but instead selectively weaken RNA and non-methylated DNA binding, thereby disrupting the competitive balance between nucleic acids. Our work establishes the MBD-ID module as MeCP2’s central nucleic acid interaction hub, whose disruption provides a potential molecular etiology of Rett syndrome due to mutations in the ID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methyl-CpG-Binding Protein 2Rett SyndromeDNARNAMethyl CpG Binding DomainHumansMutationProtein BindingDNA MethylationAnimalsBinding Sites

Substanzen

Methyl-CpG-Binding Protein 2DNARNAMECP2 protein, human

Autor:innen und Institutionen

  • Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO 80309, U.S.A.
  • Department of Biochemistry, University of Colorado Boulder, Boulder, CO 80309, USA.

ORCID-Profile: Josiah A Peter, Thomas A Weiser, Lee A Niswander, Robert T Batey, Deborah S Wuttke

Förderung

  • NCRR NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • Innovation Award from the International Rett Syndrome Foundation
  • The Shurl and Kay Curci Foundation
  • NIH

Zitieren

APA

Peter, J. A., Weiser, T. A., Niswander, L. A., Batey, R. T., & Wuttke, D. S. (2026). MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag890

Vancouver

Peter JA, Weiser TA, Niswander LA, Batey RT, Wuttke DS. MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag890

BibTeX
@article{Peter2026,
  author = {Peter, Josiah A and Weiser, Thomas A and Niswander, Lee A and Batey, Robert T and Wuttke, Deborah S},
  title = {MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkag890}
}
Kostenlos starten →